HHS, ASPR, the Food and Drug Administration (FDA), and the Centers for Disease Control and Prevention (CDC) continue to use all available authorities to protect patients, support supply, and keep stakeholders informed, in partnership with manufacturers, distributors, hospitals, and other stakeholders. As a result of these steps, hospitals have 50% more product available to them now compared to right after the hurricane. Additionally, HHS announced additional information about the airlift of Baxter products into the U.S. from international facilities. The first flights started on October 19, 2024.
Learn more about the actions HHS is taking in a recently released fact sheet on the Hurricane response.